Evidence map›Paper›PMID 30795981›Full record

ArticleCell host & microbe2019

Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations.

Jiwon Lee, Philipp Paparoditis, Andrew P Horton, Alexander Frühwirth, Jonathan R McDaniel, Jiwon Jung, Daniel R Boutz, Dania A Hussein, Yuri Tanno, Leontios Pappas and 4 more

Abstract read
In one paragraph

Article in Cell host & microbe, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. AI-Driven BCR Modeling for Precision Immunology.International journal of molecular sciences · 2026
    Review
  7. Explore antibody repertoire in the era of AI.Acta biochimica et biophysica Sinica · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. A Handle on Mass Coincidence Errors inJournal of proteome research · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Jiwon LeeDepartment of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
Philipp PaparoditisInstitute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona 6500, Switzerland; Institute of Microbiology, ETH Zürich, Zürich 8093, Switzerland.
Andrew P HortonCenter for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712, USA.
Alexander FrühwirthInstitute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona 6500, Switzerland.
Jonathan R McDanielDepartment of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
Jiwon JungDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
Daniel R BoutzCenter for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712, USA.
Dania A HusseinDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Yuri TannoDepartment of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
Leontios PappasInstitute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona 6500, Switzerland.
Gregory C IppolitoDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Davide CortiHumabs BioMed, Bellinzona 6500, Switzerland.
Antonio LanzavecchiaInstitute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona 6500, Switzerland; Institute of Microbiology, ETH Zürich, Zürich 8093, Switzerland.
George GeorgiouDepartment of Chemical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712, USA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: gg@che.utexas.edu.

Funding

Virology CoreP01AI089618 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI Jiwon Lee · 2011 to 2026
$40.0M
European Research Council 670955NIAID NIH HHS P01 AI089618
6 · The paper itself

Abstract

Humans are repeatedly exposed to influenza virus via infections and vaccinations. Understanding how multiple exposures and pre-existing immunity impact antibody responses is essential for vaccine development. Given the recent prevalence of influenza H1N1 A/California/7/2009 (CA09), we examined the clonal composition and dynamics of CA09 hemagglutinin (HA)-reactive IgG repertoire over 5 years in a donor with multiple influenza exposures. The anti-CA09 HA polyclonal response in this donor comprised 24 persistent antibody clonotypes, accounting for 72.6% ± 10.0% of the anti-CA09 HA repertoire over 5 years. These persistent antibodies displayed higher somatic hypermutation relative to transient serum antibodies detected at one time point. Additionally, persistent antibodies predominantly demonstrated cross-reactivity and potent neutralization toward a phylogenetically distant H5N1 A/Vietnam/1203/2004 (VT04) strain, a feature correlated with HA stem recognition. This analysis reveals how "serological imprinting" impacts responses to influenza and suggests that once elicited, cross-reactive antibodies targeting the HA stem can persist for years.

Indexed as

Immunity, HumoralAntibodies, ViralFemaleHemagglutinin Glycoproteins, Influenza VirusHumansImmunoglobulin GInfluenza, HumanInfluenza VaccinesMiddle AgedOrthomyxoviridaeSerumSwitzerlandAntibodies, ViralH1N1 virus hemagglutininHemagglutinin Glycoproteins, Influenza VirusImmunoglobulin GInfluenza Vaccinesanti-hemagglutinin antibodieshumoral immunityimmunological imprintinginfluenza vaccine responselongitudinal profilingpersistent antibodiesserum antibody repertoire

Identifiers

PMID30795981
PMCPMC6417944

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.